Stay updated on ARO-APOC3 in Mixed Dyslipidemia Clinical Trial

Sign up to get notified when there's something new on the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for the completed plozasiran study is displayed, with study design, participant criteria, locations, outcome measures, and posted documents.
    Difference
    67%
    Check dated 2026-11-09T13:14:00.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T12:50:09.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces NIH website transition updates and says NIH content may use “Super Intelligence” in place of “Artificial Intelligence.” It appears above the 403 error page for the study record.
    Difference
    1%
    Check dated 2026-10-26T12:56:59.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The error page’s footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T13:31:36.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The site’s footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:18.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden page with a standard header/footer, replacing the study content and effectively hiding the trial details from public view.
    Difference
    19%
    Check dated 2026-09-21T21:57:18.000Z thumbnail image

Stay in the know with updates to ARO-APOC3 in Mixed Dyslipidemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in Mixed Dyslipidemia Clinical Trial page.